These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 8239161

  • 21. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A.
    N Engl J Med; 1997 Nov 13; 337(20):1405-11. PubMed ID: 9358137
    [Abstract] [Full Text] [Related]

  • 22. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects.
    Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ.
    Am Rev Respir Dis; 1991 Jan 13; 143(1):109-13. PubMed ID: 1986667
    [Abstract] [Full Text] [Related]

  • 23. Budesonide treatment of moderate and severe asthma in children: a dose-response study.
    Pedersen S, Hansen OR.
    J Allergy Clin Immunol; 1995 Jan 13; 95(1 Pt 1):29-33. PubMed ID: 7822661
    [Abstract] [Full Text] [Related]

  • 24. Effect of disease duration on dose-response of inhaled budesonide in asthma.
    Selroos O.
    Respir Med; 2008 Jul 13; 102(7):1065-72. PubMed ID: 18387797
    [Abstract] [Full Text] [Related]

  • 25. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
    Prieto L, Gutiérrez V, Morales C.
    Eur Respir J; 1999 Jun 13; 13(6):1236-44. PubMed ID: 10445596
    [Abstract] [Full Text] [Related]

  • 26. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D, Vagaggini B, Bacci E, Fabbri LM, Giuntini C.
    Am J Respir Crit Care Med; 1994 Jun 13; 149(6):1447-51. PubMed ID: 8004297
    [Abstract] [Full Text] [Related]

  • 27. Asthma control during and after cessation of regular beta 2-agonist treatment.
    Wahedna I, Wong CS, Wisniewski AF, Pavord ID, Tattersfield AE.
    Am Rev Respir Dis; 1993 Sep 13; 148(3):707-12. PubMed ID: 8103655
    [Abstract] [Full Text] [Related]

  • 28. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.
    Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, O'Byrne PM, START Investigators Group.
    J Allergy Clin Immunol; 2008 May 13; 121(5):1167-74. PubMed ID: 18405951
    [Abstract] [Full Text] [Related]

  • 29. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma.
    Anderson SD, du Toit JI, Rodwell LT, Jenkins CR.
    Chest; 1994 Mar 13; 105(3):673-80. PubMed ID: 8131524
    [Abstract] [Full Text] [Related]

  • 30. Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma.
    O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW.
    Am Rev Respir Dis; 1992 Sep 13; 146(3):560-4. PubMed ID: 1519828
    [Abstract] [Full Text] [Related]

  • 31. Does ketotifen have a steroid-sparing effect in childhood asthma?
    Canny GJ, Reisman J, Levison H.
    Eur Respir J; 1997 Jan 13; 10(1):65-70. PubMed ID: 9032494
    [Abstract] [Full Text] [Related]

  • 32. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S, Chapman KR, Broder I, Cartier A, Hyland RH, Knight A, Malo JL, Mazza JA, Moote DW, Small P.
    Am Rev Respir Dis; 1991 Sep 13; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [Abstract] [Full Text] [Related]

  • 33. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.
    Respir Med; 2000 Aug 13; 94(8):767-71. PubMed ID: 10955752
    [Abstract] [Full Text] [Related]

  • 34. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H, Willenbrock U, Jörres R.
    Med Klin (Munich); 1995 Apr 15; 90(4):214-9. PubMed ID: 7776933
    [Abstract] [Full Text] [Related]

  • 35. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma.
    Sears MR, Taylor DR, Print CG, Lake DC, Herbison GP, Flannery EM.
    Chest; 1992 Dec 15; 102(6):1709-15. PubMed ID: 1446477
    [Abstract] [Full Text] [Related]

  • 36. Inhaled steroids treatment and withdrawal in asthmatic children.
    Farrero E, Llunell A, Cañete C, Rodríguez B, Manresa F, Romero PV.
    Allergol Immunopathol (Madr); 1995 Dec 15; 23(4):182-8. PubMed ID: 8553993
    [Abstract] [Full Text] [Related]

  • 37. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
    Kuo HP, Yu TR, Yu CT.
    Eur Respir J; 1994 Aug 15; 7(8):1452-9. PubMed ID: 7957830
    [Abstract] [Full Text] [Related]

  • 38. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, de Boeck K.
    Pediatr Pulmonol; 2002 Nov 15; 34(5):342-50. PubMed ID: 12357478
    [Abstract] [Full Text] [Related]

  • 39. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
    Waalkens HJ, Gerritsen J, Koëter GH, Krouwels FH, van Aalderen WM, Knol K.
    Thorax; 1991 Jul 15; 46(7):499-503. PubMed ID: 1877037
    [Abstract] [Full Text] [Related]

  • 40. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J, Zuck P, Dennewald G, Dugue P, Grivaux M, Brun P, Severac JC, Ostinelli J, Cheeseman KH.
    Adv Ther; 1996 Jul 15; 13(1):38-50. PubMed ID: 10172710
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.